Increased dosing regimens of piperacillin-tazobactam are needed to avoid subtherapeutic exposure in critically ill patients with augmented renal clearance

Detalles Bibliográficos
Autores principales: Besnard, Thibaud, Carrié, Cédric, Petit, Laurent, Biais, Matthieu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335799/
https://www.ncbi.nlm.nih.gov/pubmed/30651133
http://dx.doi.org/10.1186/s13054-019-2308-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335799/
https://www.ncbi.nlm.nih.gov/pubmed/30651133
http://dx.doi.org/10.1186/s13054-019-2308-x

Ejemplares similares